Impact of a pulmonary embolism response team initiative on hospital mortality of patients with bilateral pulmonary embolism.

Catheter-directed therapies Embolia pulmonar Equipos de respuesta multidisciplinar Fibrinólisis Pulmonary embolism Pulmonary embolism response teams Reperfusion therapy Terapias de reperfusión Terapias dirigidas por catéter Thrombolysis

Journal

Medicina clinica
ISSN: 1578-8989
Titre abrégé: Med Clin (Barc)
Pays: Spain
ID NLM: 0376377

Informations de publication

Date de publication:
09 06 2023
Historique:
received: 01 07 2022
revised: 01 12 2022
accepted: 03 12 2022
medline: 7 6 2023
pubmed: 22 2 2023
entrez: 21 2 2023
Statut: ppublish

Résumé

Pulmonary embolism (PE) response teams (PERT) for the management of high-risk PE (HR-PE) and intermediate-high risk PE (IHR-PE) are encouraged in PE guidelines. We aimed to assess the impact of a PERT initiative on mortality in these groups of patients, compared with standard care. We conducted a prospective, single-center registry, including consecutive patients with HR-PE and IHR-PE with PERT activation from February-2018 to December-2020 (PERT group, n=78 patients) and compared it with an historic cohort of patients admitted to our hospital in a previous 2-year period (2014-2016), managed with standard of care (SC-group, n=108 patients). Patients in the PERT group were younger and less comorbid. The risk profile at admission and the percentage of HR-PE was similar in both cohorts (13% in SC-group and 14% in PERT-group, p=0.82). Reperfusion therapy was more frequently indicated in PERT-group (24.4% vs 10.2%, p=0.01), with no differences in fibrinolysis treatment, while catheter-directed therapy (CDT) was more frequent in PERT group (16.7% vs 1.9%, p<0.001). Reperfusion and CDT were associated with lower in-hospital mortality (2.9% vs 15.1%, p=0.001 for reperfusion and 1.5% vs 16.5%, p=0.001 for CDT). The primary outcome, 12-month mortality, was lower in the PERT-group (9% vs 22.2%, p=0.02), There were no differences in 30-day readmissions. In multivariate analysis PERT activation was associated with lower mortality at 12 months (HR 0.25, 95% confidence interval 0.09-0.7, p=0.008). A PERT initiative in patients with HR-PE and IHR-PE was associated with a significant reduction in 12-month mortality compared with standard of care, and also with an increase in the use of reperfusion, especially catheter-directed therapies.

Identifiants

pubmed: 36801109
pii: S0025-7753(23)00017-9
doi: 10.1016/j.medcli.2022.12.017
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

469-475

Investigateurs

Francisco Javier Noriega (FJ)
Pablo Zulet Fraile (PZ)
Fabián Islas (F)
Carlos Real (C)
Hernán Mejía-Rentería (H)
Pilar Jiménez-Quevedo (P)
Nieves Gonzalo (N)
Iván Nuñez-Gil (I)
Luis Nombela-Franco (L)
Gabriela Tirado (G)
Fernando Macaya (F)
Javier Escaned (J)
Ana María Mañas Hernández (AMM)
José Bustamante (J)
Mónica Pérez Serrano (MP)
Esther Bernardo García (EB)
María Aranzazu Ortega Pozzi (MAO)
Javier Higueras (J)
Alberto de Agustín (A)
Ana Viana-Tejedor (A)
Antonio Fernández-Ortiz (A)

Informations de copyright

Copyright © 2023 Elsevier España, S.L.U. All rights reserved.

Auteurs

Noemi Ramos-López (N)

Cardiovascular Institute, Hospital Universitario Clínico San Carlos, Madrid,Spain.

Carlos Ferrera (C)

Cardiovascular Institute, Hospital Universitario Clínico San Carlos, Madrid,Spain.

Tania Luque (T)

Cardiovascular Institute, Hospital Universitario Clínico San Carlos, Madrid,Spain.

Daniel Enríquez-Vázquez (D)

Cardiovascular Institute, Hospital Universitario Clínico San Carlos, Madrid,Spain.

Patricia Mahía-Casado (P)

Cardiovascular Institute, Hospital Universitario Clínico San Carlos, Madrid,Spain.

Laura Galván-Herráez (L)

Radiology Department, Hospital Universitario Clínico San Carlos, Madrid,Spain.

José María Pedrajas (JM)

Internal Medicine Department, Hospital Universitario Clínico San Carlos, Madrid,Spain.

Pablo Salinas (P)

Cardiovascular Institute, Hospital Universitario Clínico San Carlos, Madrid,Spain. Electronic address: salinas.pablo@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH